Production of rIL-22 by engineered Lactobacillus reuteri can also ameliorate hepatic steatosis in mice with diet-induced obesity, as evidenced by reduced triglyceride levels and liver weight via the IL-22/STAT3/Reg3 cascade [94]. The gene discussed is STAT3; the disease is fatty liver disease.